Dx4Life

An increasing number of couples struggle to have children globally, resulting in a rising need for in vitro fertilization (IVF) treatments. But IVF is neither easy nor smooth. The key to better results is giving each individual the right hormone treatment prior to the IVF. 

The problem is that there has not been any clinically useful biomarker available to reliably know what hormone to use in each case.

In her research, founder and professor Yvonne Lundberg Giwercman discovered a novel biomarker that reliably determines what hormone treatment each patient should have  - thereby radically improving the odds for pregnancy. This has paved the way for a simple test can be used on-site by the clinics.
 

Dx4Life´s website